… relapse (TTR) and overall survival (OS) based on grouping determined by receptor status
as follows: estrogen receptor (ER)-positive and any progesterone receptor (PgR) expression (…

… dying of breast cancer which was correctly predicted by the index, and specificity as the
percentage of patients surviving which the index predicted correctly. A receiver/response …

… We also evaluated survival outcome in patients with anti-HER2 treatment (Figure 1C and
F). HR+/HER2+ patients had better DFS (P = .002) than HR-/HER2+ subtype. There was no …

… A few investigators have reported information relating the disease-free survival (DFS) or
survival (S) of patients who received adjuvant chemotherapy with the ER of their primary tumors (…

… RI, Griffiths K: Relationship of estrogen receptor status to survival in breast cancer. Lancet
ii:… estrogen receptor determinations in patients with primary breast cancer: an update. Cancer …

… Patients with TN tumors shared many clinical, … survival that was very similar survival to
that of patients with DN tumors, and survival for both groups contrasted greatly with survival for …

… phenomenon, prospective trials are needed to evaluate whether or not this discordance
has any impact on patient outcomes in terms of either progression free or overall survival. …

… prolonged disease-free intervals and overall survival for patients with primary disease,'-"
and it correlates with response to endocrine therapy in patients with advanced disease. 6 More …

… examining the risk of tumorigenesis in patients using hormonal contraception. Studies
exploring estrogen-only and estrogen/progesterone combination contraceptives have failed to …

… an important role for estrogen (ER), progesterone (PR), and … Patients with tumors in which
more than 10% of cells had … 5-year survival = 51.9 months) than did patients with tumors in …